Fate Therapeutics (FATE) EBT Margin Growth (1y) (2013 - 2026)
Fate Therapeutics (FATE) EBT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 452.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,076.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9,422.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,911.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,565.00 |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - | -106,599.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106,599.00 |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 217,820.00 |
| Jun 30, 2025 | 53,489.00 |
| Mar 31, 2025 | -489,545.00 |
| Dec 31, 2024 | -64,384.00 |
| Sep 30, 2024 | 446,027.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -525,585.00 |
| Dec 31, 2023 | -2.11 Mn |
| Sep 30, 2023 | -992,666.00 |
| Jun 30, 2023 | -1.16 Mn |
| Mar 31, 2023 | 33,483.00 |
| Dec 31, 2022 | 92,684.00 |
| Sep 30, 2022 | 66,403.00 |
| Jun 30, 2022 | -49,420.00 |
| Mar 31, 2022 | 66,865.00 |
| Dec 31, 2021 | -61,923.00 |
| Sep 30, 2021 | 127,726.00 |
| Jun 30, 2021 | 313,484.00 |